JP2016505026A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016505026A5 JP2016505026A5 JP2015553034A JP2015553034A JP2016505026A5 JP 2016505026 A5 JP2016505026 A5 JP 2016505026A5 JP 2015553034 A JP2015553034 A JP 2015553034A JP 2015553034 A JP2015553034 A JP 2015553034A JP 2016505026 A5 JP2016505026 A5 JP 2016505026A5
- Authority
- JP
- Japan
- Prior art keywords
- granules
- crystalline cellulose
- gum
- sugar
- mesh screen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008187 granular material Substances 0.000 description 5
- 229920000084 Gum arabic Polymers 0.000 description 3
- 239000000205 acacia gum Substances 0.000 description 3
- 235000010489 acacia gum Nutrition 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 239000000654 additive Substances 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- QXKAIJAYHKCRRA-JJYYJPOSSA-N D-arabinonic acid Chemical class OC[C@@H](O)[C@@H](O)[C@H](O)C(O)=O QXKAIJAYHKCRRA-JJYYJPOSSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229920003110 Primojel Polymers 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000008202 granule composition Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229920003109 sodium starch glycolate Polymers 0.000 description 1
- 229940079832 sodium starch glycolate Drugs 0.000 description 1
- 239000008109 sodium starch glycolate Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13075002 | 2013-01-15 | ||
| EP13075002.9 | 2013-01-15 | ||
| PCT/EP2014/000091 WO2014111254A1 (en) | 2013-01-15 | 2014-01-14 | Composition of tiacumicin compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016505026A JP2016505026A (ja) | 2016-02-18 |
| JP2016505026A5 true JP2016505026A5 (OSRAM) | 2017-02-02 |
| JP6338598B2 JP6338598B2 (ja) | 2018-06-06 |
Family
ID=47563169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015553034A Active JP6338598B2 (ja) | 2013-01-15 | 2014-01-14 | チアクマイシン化合物の組成物 |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US9808530B2 (OSRAM) |
| EP (1) | EP2945613B1 (OSRAM) |
| JP (1) | JP6338598B2 (OSRAM) |
| KR (1) | KR102181474B1 (OSRAM) |
| CN (1) | CN105120840B (OSRAM) |
| AR (1) | AR094495A1 (OSRAM) |
| AU (1) | AU2014207083B2 (OSRAM) |
| CA (1) | CA2904808A1 (OSRAM) |
| CY (1) | CY1121459T1 (OSRAM) |
| DK (1) | DK2945613T3 (OSRAM) |
| EA (1) | EA030049B1 (OSRAM) |
| ES (1) | ES2705238T3 (OSRAM) |
| GE (1) | GEP201706769B (OSRAM) |
| HR (1) | HRP20182110T1 (OSRAM) |
| HU (1) | HUE041421T2 (OSRAM) |
| IL (1) | IL239899A0 (OSRAM) |
| JO (1) | JO3464B1 (OSRAM) |
| LT (1) | LT2945613T (OSRAM) |
| MD (1) | MD4588C1 (OSRAM) |
| NZ (1) | NZ710875A (OSRAM) |
| PL (1) | PL2945613T3 (OSRAM) |
| PT (1) | PT2945613T (OSRAM) |
| RS (1) | RS58119B1 (OSRAM) |
| SI (1) | SI2945613T1 (OSRAM) |
| TW (1) | TWI646962B (OSRAM) |
| UA (1) | UA117004C2 (OSRAM) |
| WO (1) | WO2014111254A1 (OSRAM) |
| ZA (1) | ZA201505048B (OSRAM) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6579662B2 (ja) * | 2014-05-09 | 2019-09-25 | アステラス ファーマ ユーロープ リミテッド | チアクマイシン化合物の治療レジメン |
| CN110037992B (zh) * | 2019-05-28 | 2021-05-28 | 杭州华东医药集团新药研究院有限公司 | 一种稳定的非达霉素组合物 |
| CN116715678B (zh) * | 2023-06-12 | 2025-09-30 | 中国科学院成都生物研究所 | 一种吲哚糖碳苷类大环化合物及其制备方法与应用 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3000792A (en) | 1957-05-21 | 1961-09-19 | Merck & Co Inc | Antibiotic adsorption process |
| GB1458512A (en) | 1973-11-22 | 1976-12-15 | Lepetit Spa | Antibiotic substance |
| US4632902A (en) | 1981-08-20 | 1986-12-30 | Becton, Dickinson And Company | Method for detecting biological activity in a body fluid |
| US4918174A (en) | 1986-09-26 | 1990-04-17 | Abbott Laboratories | Tiacumicin compounds |
| CA2384519C (en) | 1991-03-04 | 2006-08-15 | Bayer Corporation | Automated analyzer |
| US5583115A (en) | 1995-05-09 | 1996-12-10 | Abbott Laboratories | Dialkyltiacumicin compounds |
| US5767096A (en) | 1996-07-12 | 1998-06-16 | Abbott Laboratories | Bromotiacumicin compounds |
| WO1998022461A1 (de) | 1996-11-18 | 1998-05-28 | GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) | Epothilone c, d, e und f, deren herstellung und deren verwendung als cytostatische mittel bzw. als pflanzenschutzmittel |
| JP2000072760A (ja) | 1998-06-19 | 2000-03-07 | Ajinomoto Co Inc | 新規シストチアゾール類縁体 |
| JP2000053514A (ja) | 1998-08-06 | 2000-02-22 | Aquas Corp | レジオネラ属細菌が生産する殺菌性物質、これを用いた殺菌剤、水処理剤、スライム抑制剤、及びこれらの製造方法 |
| JP2000239266A (ja) | 1999-02-17 | 2000-09-05 | Ajinomoto Co Inc | 新規ポリエン系抗生物質 |
| AU2001295195B2 (en) | 2000-04-28 | 2007-02-01 | Kosan Biosciences, Inc. | Myxococcus host cells for the production of epothilones |
| WO2002032427A1 (en) | 2000-10-20 | 2002-04-25 | Galephar M/F | Stable oral formulation containing benzimidazole derivative |
| US20030099699A1 (en) | 2001-11-13 | 2003-05-29 | Hanshew Dwight D. | Storage stable thyroxine active drug formulations and methods for their production |
| JP2005534332A (ja) | 2002-07-29 | 2005-11-17 | オプティマー ファーマシューティカルズ、インコーポレイテッド | チアクマイシン生産 |
| US20070105791A1 (en) | 2002-07-29 | 2007-05-10 | Optimer Pharmaceuticals, Inc. | Method of treating clostridium difficile-associated diarrhea |
| US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
| US20080206161A1 (en) * | 2002-10-25 | 2008-08-28 | Dov Tamarkin | Quiescent foamable compositions, steroids, kits and uses thereof |
| US20040224020A1 (en) | 2002-12-18 | 2004-11-11 | Schoenhard Grant L. | Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats |
| JP4640821B2 (ja) | 2003-07-24 | 2011-03-02 | 塩野義製薬株式会社 | 難水溶性薬物を含むドライシロップ剤 |
| JP3881640B2 (ja) | 2003-08-08 | 2007-02-14 | 塩野義製薬株式会社 | ロラタジンを含むドライシロップ剤 |
| EP1765312B1 (en) | 2004-05-14 | 2011-07-13 | Optimer Pharmaceuticals, Inc. | Treatment of diseases associated with the use of antibiotics |
| US7906489B2 (en) | 2004-05-14 | 2011-03-15 | Optimer Pharmaceuticals, Inc. | 18-membered macrocycles and analogs thereof |
| BRPI0519890A2 (pt) | 2005-01-31 | 2009-03-31 | Optimer Pharmaceuticals Inc | macrociclos de 18 elementos e seus análogos |
| US7378508B2 (en) | 2007-01-22 | 2008-05-27 | Optimer Pharmaceuticals, Inc. | Polymorphic crystalline forms of tiacumicin B |
| US20110104267A1 (en) * | 2005-04-25 | 2011-05-05 | Aurobindo Pharma Limited | Pharmaceutical compositions of antiretrovirals |
| EP1940417A4 (en) | 2005-10-21 | 2010-07-07 | Optimer Pharmaceuticals Inc | METHOD FOR TREATING DIARRHOE IN CONNECTION WITH CLOSTRIDIUM DIFFICILE |
| US20080176927A1 (en) | 2007-01-19 | 2008-07-24 | Optimer Pharmaceuticals, Inc. | Compositions of stable tiacumicins |
| ZA200905337B (en) | 2007-01-22 | 2010-10-27 | Optimer Pharmaceuticals Inc | Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof |
| US8999395B2 (en) | 2007-02-09 | 2015-04-07 | Ceva Sante Animale | Pharmaceutical compositions for oral administration in the form of stabilised aqueous suspensions |
| TWI523654B (zh) | 2007-11-27 | 2016-03-01 | 默沙東藥廠 | 抗生素巨環化合物以及其製造及使用之方法 |
| JP5608880B2 (ja) * | 2010-02-09 | 2014-10-22 | 林兼産業株式会社 | 嚥下困難者用高栄養ゼリー食品 |
| CN102030791B (zh) | 2010-10-28 | 2013-01-23 | 中国科学院南海海洋研究所 | 四种台勾霉素类化合物及其制备方法和在制备抗菌药物中的应用 |
| CN102115757B (zh) | 2010-12-14 | 2015-10-28 | 中国科学院南海海洋研究所 | 台勾霉素的生物合成基因簇及其应用 |
-
2014
- 2014-01-13 JO JOP/2014/0006A patent/JO3464B1/ar active
- 2014-01-14 JP JP2015553034A patent/JP6338598B2/ja active Active
- 2014-01-14 CA CA2904808A patent/CA2904808A1/en not_active Abandoned
- 2014-01-14 RS RS20181542A patent/RS58119B1/sr unknown
- 2014-01-14 SI SI201430997T patent/SI2945613T1/sl unknown
- 2014-01-14 PL PL14701907T patent/PL2945613T3/pl unknown
- 2014-01-14 DK DK14701907.9T patent/DK2945613T3/en active
- 2014-01-14 WO PCT/EP2014/000091 patent/WO2014111254A1/en not_active Ceased
- 2014-01-14 NZ NZ71087514A patent/NZ710875A/en not_active IP Right Cessation
- 2014-01-14 CN CN201480015374.9A patent/CN105120840B/zh not_active Expired - Fee Related
- 2014-01-14 US US14/766,904 patent/US9808530B2/en active Active
- 2014-01-14 UA UAA201506802A patent/UA117004C2/uk unknown
- 2014-01-14 HR HRP20182110TT patent/HRP20182110T1/hr unknown
- 2014-01-14 EP EP14701907.9A patent/EP2945613B1/en active Active
- 2014-01-14 LT LTEP14701907.9T patent/LT2945613T/lt unknown
- 2014-01-14 ES ES14701907T patent/ES2705238T3/es active Active
- 2014-01-14 KR KR1020157021986A patent/KR102181474B1/ko not_active Expired - Fee Related
- 2014-01-14 MD MDA20150070A patent/MD4588C1/ro active IP Right Grant
- 2014-01-14 GE GEAP201413898A patent/GEP201706769B/en unknown
- 2014-01-14 EA EA201591226A patent/EA030049B1/ru unknown
- 2014-01-14 HU HUE14701907A patent/HUE041421T2/hu unknown
- 2014-01-14 PT PT14701907T patent/PT2945613T/pt unknown
- 2014-01-14 AU AU2014207083A patent/AU2014207083B2/en not_active Ceased
- 2014-01-15 AR ARP140100152A patent/AR094495A1/es unknown
- 2014-01-15 TW TW103101528A patent/TWI646962B/zh not_active IP Right Cessation
-
2015
- 2015-07-12 IL IL239899A patent/IL239899A0/en active IP Right Grant
- 2015-07-14 ZA ZA2015/05048A patent/ZA201505048B/en unknown
-
2018
- 2018-12-28 CY CY20181101410T patent/CY1121459T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015537066A5 (ja) | 乾燥タイプの接合化合物組成物濃縮物 | |
| JP2009235073A5 (OSRAM) | ||
| SG190448A1 (en) | Rapidly dispersing granules, orally disintegrating tablets and methods | |
| RU2020119391A (ru) | Получение тетрациклического соединения, содержащегося в высокой дозе | |
| JP2016505026A5 (OSRAM) | ||
| JP2017078163A5 (OSRAM) | ||
| JP2016539949A5 (OSRAM) | ||
| JP2016073898A5 (OSRAM) | ||
| JP2015523303A5 (OSRAM) | ||
| CN104396774B (zh) | 一种添加多种吸水成分的混合型猫砂及其制备方法 | |
| JP2016108327A5 (OSRAM) | ||
| JP2019505549A5 (OSRAM) | ||
| CA2796541A1 (en) | Lozenges of erythritol and isomalt | |
| JP2015231600A5 (OSRAM) | ||
| CN102690361A (zh) | 一种具有吸附缓释能力的糯米变性淀粉的制备方法 | |
| RU2007135607A (ru) | Способ приготовления белково-углеводного продукта | |
| JP2016053063A5 (OSRAM) | ||
| WO2018069804A3 (en) | New furazidin compositions and methods of their manufacture | |
| RU2016125712A (ru) | ФАРМАЦЕВТИЧЕСКИЙ КОМБИНИРОВАННЫЙ ПРЕПАРАТ, СОДЕРЖАЩИЙ ИНГИБИТОР HMG-СоА РЕДУКТАЗЫ И ИНГИБИТОР АБСОРБЦИИ ХОЛЕСТЕРИНА | |
| RU2012145868A (ru) | Высушенный распылительной сушкой кристаллический активный ингредиент | |
| RU2015110460A (ru) | Способ получения сахарсодержащего продукта | |
| JP2008043326A5 (OSRAM) | ||
| RU2013158815A (ru) | Гидроксиэтилцеллюлоза с низкой степенью молярного замещения и равномерным распределением заместителей в основной цепи для применения в системах на основе цемента | |
| CN110913864A (zh) | 一种稳定型烟酰胺核糖组合物及其制备方法 | |
| JP2011177698A5 (OSRAM) |